Structures by: Sribala R.
Total: 7
Diethyl 1-(4-chlorobenzyl)-4-(4-chlorophenyl)-2,2-dioxo-3,4,6,7,8,8a-hexahydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]thiazine-1,3-dicarboxylate
C26H29Cl2NO6S
Acta Crystallographica Section E (2018) 74, 9 1267-1271
a=11.6596(4)Å b=14.5734(4)Å c=15.7000(5)Å
α=90° β=104.635(2)° γ=90°
Diethyl 1-(4-methylbenzyl)-4-(4-methylphenyl)-2,2-dioxo-3,4,6,7,8,8a-hexahydro-1<i>H</i>-pyrrolo[2,1-<i>c</i>][1,4]thiazine-1,3-dicarboxylate
C28H35NO6S
Acta Crystallographica Section E (2018) 74, 9 1267-1271
a=11.8641(5)Å b=14.4765(6)Å c=15.8654(7)Å
α=90° β=104.960(2)° γ=90°
5''-(2-Chlorobenzylidene)-4'-(2-chlorophenyl)-1'-methyldispiro[acenaphthene-1,2'-pyrrolidine-3',3''-piperidine]-2,4''-dione
C34H28Cl2N2O2
Acta Crystallographica Section E (2019) 75, 10 1456-1462
a=8.6710(4)Å b=15.6756(7)Å c=20.2284(9)Å
α=90° β=93.036(2)° γ=90°
1-(4-Chlorophenyl)-8-(4-fluorophenyl)-4-[(<i>E</i>)-(4- fluorophenyl)methylidene]-6-methyl-4,5,6,7,7a,8-hexahydro- 1,2,4-oxadiazolo[5,4-<i>d</i>]pyrido[3,4-<i>c</i>][1,5]benzothiazepine
C33H26ClF2N3OS
Acta Crystallographica Section E (2007) 63, 11 o4268-o4268
a=10.836(5)Å b=11.366(4)Å c=23.100(3)Å
α=90.0° β=92.630(10)° γ=90.0°
4'-(2,4-Dichlorophenyl)-1,1'-dimethylpiperidine-3-spiro-3'- pyrrolidine-2'-spiro-3''-indoline-4,2''-dione
C23H23Cl2N3O2
Acta Crystallographica Section E (2010) 66, 3 o717
a=7.9398(2)Å b=10.8747(3)Å c=13.5367(4)Å
α=66.561(2)° β=77.8730(10)° γ=83.203(2)°
1-Methyl-1'-(4-methylphenyl)-2',3',5',6',7',7a'-hexahydro-1'<i>H</i>- dispiro[piperidine-3,2'-pyrrolizine-3',3''-indoline]-4,2''-dione
C26H29N3O2
Acta Crystallographica Section E (2012) 68, 9 o2772-o2773
a=8.7516(4)Å b=12.4649(5)Å c=21.4605(8)Å
α=97.654(2)° β=101.024(2)° γ=102.345(2)°
1'-Methyl-5''-(2-methylbenzylidene)-4'-(2-methylphenyl)dispiro[acenaphthene-1,2'-pyrrolidine-3',3''-piperidine]-2,4''-dione
C36H34N2O2
Acta Crystallographica Section E (2019) 75, 10 1456-1462
a=8.7507(5)Å b=15.9089(8)Å c=20.2879(10)Å
α=90° β=92.935(2)° γ=90°